Immunotherapy advances in head and neck cancer care: implications for prescribers
Aysha Mendes discusses how pembrolizumab is reshaping the treatment of locally advanced head and neck cancer by introducing immunotherapy into treatment and care, requiring prescribers to recognise and support co-ordinated, patient-centred management across settings
Authors
- Aysha Mendes
Publication Details
- Journal
- Journal of Prescribing Practice
- Published
- 2026-04-02
- DOI
- https://doi.org/10.12968/jprp.2026.0040
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00